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In vitro activity of antibiotics and combinations against 
Brucella melitensis 
Clin Mic-vobiol h f i c t  1997; 3: 503-506 
Brucellosis is distributed worldwide and remains 
endemic in many parts of the developed world [I]. The 
treatment of brucellosis requires combined regimens of 
antibiotics and is conditioned by the fact that brucellae 
are intracellular pathogens; thus, agents with a good 
capacity to penetrate macrophages are required for 
successful treatment. The regimen recommended for 
the treatment of brucellosis is a combination of oral 
tetracycline and intramuscular streptomycin. Another 
regimen used is doxycycline (DOX) plus rifampin 
W F )  1231. 
Ciprofloxacin (CIP) and other quinolones have 
been shown to be active in vitro against Brrirella 
melitensis [4]. Azithromycin (AZI) is a 1 5-membered 
ring azalide antibiotic. In view of the excellent levels 
attained by the quinolones and AZI within the 
macrophage, these agents could be useful alternatives in 
the treatment of brucellosis [5]. The purpose of this 
study was to determine the in vitro activity of KIF, 
DOX, CIP and AZI against B. rizelitensis clinical isolates 
and to investigate the in vitro activity of combinations 
such as DOX-CIP, CIP-KIF, DOX-RIF, RIF-AZI 
and DOX-AZI against €3. melitenris. 
The 42 B. rielitensic strains studied were clinical 
isolates from patients with brucellosis at the Erciyes 
University Hospital (Kayseri, Turkey). All strains were 
maintained as frozen stocks (-70°C) and twice sub- 
cultured before starting the studies.The antibiotics 
evaluated in this study were obtained from their 
manufacturers as laboratory powder (RIF, Lepetit-Sifar, 
Turkey; DOX, Fako, Turkey; CI? Eczaclbqi, Turkey; 
AZI, Pfizer, Turkey). 
MICs were determined by the agar dilution 
technique using Mueller-Hinton agar (Oxoid, UK) as 
recommended by the National Committee for Clinical 
Laboratory Standards [6]. The range of concentrations 
was from 128 to 0.015 pg/mL for all the antibiotics 
tested. Inocula were prepared by making a suspension 
of B. melitensis colonies from subcultures on Bnrcella 
agar (Oxoid, UK) into Mueller-Hinton broth (Oxoid, 
UK). Plates of Mueller-Hinton agar were inoculated 
with approximately 104-105 colony-forming units 
(CFUs) per spot. Control strains (Staphylococcus aweus 
ATCC 29213 and Esclzericliia ndi ATCC 25922) were 
included in all studies. Plates of Mueller-Hinton agar 
without antibiotic were used as controls. Plates were 
incubated at 35°C for 48 h, and the MlCs were 
determined. The MICs were defined as the lowest 
concentrations of antibiotics that prevented visible 
growth on the agar surface. 
The activities of the DOX-CIP, CIP-KIF, 
DOX-RIF, RIF-AZI and DOX-AZI combinations 
were determined by a two-diniensional checkerboard 
agar dilution method [7]. The concentrations tested 
for each antibiotic typically ranged from four to five 
dilutions below the MIC to two dilutions above the 
MIC, using two-fold dilutions of each antibiotic in 
Mueller-Hinton agar. One of the antibiotics was diluted 
along the abscissa and the other along the ordinate, 
thereby providing all possible two-fold combinations of 
the antibiotic concentrations. Plates were inoculated 
and MICs were determined after incubation as described 
above. 
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Figure 1 Checkerboard assay: distribution of the FIC indices. 
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The fractional inhibitory concentration (FIC) (i.e., 
the ratio of the MIC of antibiotic A in the combination 
and the MIC of antibiotic A alone) was calculated for 
each antibiotic in each combination. The FICs for the 
two antibiotics in each row were then summed as 
follows: 
A / M I C ~  + B/MICe = FICA+ FICB -= FIC index 
where A is the concentration of drug A in an agar plate 
that is the lowest inhibitory concentration in its row, 
MICA is the MIC of the organism to drug A alone, 
FICA is the fractional inhibitory concentration of drug 
A, and MICR and FICB are defined similarly for drug 
B. O f  the FIC indices calculated for all rows in the 
checkerboard, the minimum value was the FIC index 
for the isolate. If the MIC of the antibiotic alone was 
greater than the highest concentration tested, the next 
dilution up was used in the calculation of the FIC 
index. The bacteriostatic activity of the combination 
is defined as synergy when the FIC index is 20.5, 
antagonism when the FIC index is 24,  partial synergy 
when the FIC index is between 0.5 and 1, and 
indifference when the FIC index is in the range 
between, i.e. 12FIC<4 [7,8]. 
DOX was the most active antibiotic in vitro against 
B. melitensis, showing the lowest MIC. MICs of DOX 
ranged from 0.06 to 1 pg/niL and the MIC9o was 0.25 
pg/niL. The MICgos of RIF (range 0.5-4 pg/mL), 
AZI (range 0.5-16 pg/mL) and CIE’ (range 0.25- 
1 pg/mL) were 2.0 pg/mL, 8 pg/mL and 0.5 pg/mL, 
respectively. 
The results of the checkerboard assay of the five 
tested combinations are summarized in Table 1. The 
DOX-AZI combination showed synergistic activity 
against B. melitensis in 33% of cases. The RIF-AZI and 
DOX-RIF combinations were synergistic against 29% 
and 12% of the B. melitensis isolates, respectively. No 
synergistic interaction was obtained with the DOX- 
CIP and CIP-RIF combinations against the 42 B. 
melitensir isolates. The frequency distributions of the 
FIC indices for the five combinations are presented 
in Figure 1. The DOX-AZI combination exhibited 
synergistic interactions of the greatest magnitude. This 
combination showed synergistic activity against 14 B. 
melitensis isolates with FIC indices 20.5. FIC indices of 
50.5 were observed in 29% of RIF-AZI and 12% of 
DOX-RIF synergistic interactions. 
Brucellae have the ability to settle within the host 
cells of the reticuloendothelial system and phagocytes, 
sites where antibiotic concentrations may not be 
optimal. Thus, it is important to use antibiotics that 
show excellent in vitro activity against brucellae and the 
ability to penetrate into cells [l]. Our  in vitro results 
demonstrate that all the antibiotics tested are active 
against B. melitensis. These results agree with previous 
findings [4,9]. Quinolones and AZI have been shown 
to penetrate well into human cells and tissues, which 
makes them suitable agents in the treatment of intra- 
cellular infections [5,10]. Although fluoroquinolone 
MICs and minimum bactericidal concentrations 
(MBCs) for brucellae are relatively low, the relapse rates 
are unacceptably high, ranging from 16%) to 66%, when 
they are used as monotherapy in brucellosis [11,12]. 
Certain characteristics of AZI (most active macrolide 
in vitro against B. melitensis, very high rate of tissue 
penetration, persisting concentration in leukocytes and 
macrophages) suggest that combinations including AZI 
may be of potential use in the treatment of brucellosis 
(notably during pregnancy). Our in vitro results 
demonstrated that the DOX-AZI and RIF-AZI com- 
binations gave synergistic interactions against 33% and 
29% of B. melitensis isolates, respectively. 
The intracellular location of brucellae in phago- 
lysosomes (pH-5.4) may be detrimental to the 
bactericidal activities of antibiotics. It is well known 
that the in vitro activity of macrolides and quinolones 
are adversely affected by low pH [13]. Although 
inactivation at acidic pH precludes quinolones and 
Table 1 Checkerboard assay of five combinations against 42 strains of B. melitensis 
Percentage of isolates with FIC indices showiiig 
Combination SYn%Y Partial synergy Indifference Antagonism 
(20.5) ( x l . 5 ,  <1) (21, <4) (2% 
DOX-ClP 0 (0/42) 5 (2/42) 76 (32/42) 19 (8/42) 
CIP-RIF 0 (0/42) 17 (7/42) 59 (25/42) 24 (10/42) 
DOX-RIF 12 (5/42) 45 (19/42) 21 (9/42) 22 (9/42) 
RIF-AZI 29 (12/42) SO (21/42) 7 (3/42) 14 (6/42) 
D OX-AZ I 33 (14/42) 33 (14/42) 10 (4/42) 24 (10/42) 
AZI=azithroniycin; CIP=ciprofloxacin; DOX=doxycycline; RIF=rifanipni. 
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macrolides as monotherapy for brucellosis, these com- 
pounds can be reserved as adjunctive agents. The recent 
WHO report states that better results are achieved 
when RIF is combined with DOX [3]. 
Combinations of quinolones and macrolides, which 
show good intracellular diffusion and act synergistically 
in vitro against B. melitensis, must be investigated in 
animal models before clinical trials are undertaken. 
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Imported trichinellosis from former Yugoslavia 
Clin hficvobiol Infect 1997; 3: 506-507 
Human trichinellosis is a worldwide anthropozoonosis, 
caused by the nematode Zickinella spiralis, and it usually 
results from the ingestion of infested raw or under- 
cooked meat from pigs, wild boars, bears, horses or 
other mammals [ 11. In western Europe, transmission 
by horses has greatly increased over the past twenty 
years, with six French outbreaks since 1977, involving 
more than 1750 people, being attributed to horsemeat 
consumption [2]. Although trichinellosis is relatively 
uncommon in Western countries, it may be acquired 
during travel in developing countries where it is 
endemic. Recently, a small outbreak of trichinellosis 
caused by smoked ham imported from the former 
Yugoslavia was reported [3]. We describe a case of 
trichinellosis occurring in a French traveler who ate 
smoked pork in Serbia. 
A previously healthy 25-year-old French man 
was admitted on 6 February 1996 with a 10-day history 
of watery diarrhea, fever, diffuse myalgia, nocturnal 
pruritus and facial edema. The patient had recently 
returned from a I-month trip to Cacak (Serbia), where 
he had eaten smoked pork between 7 and 10 January 
1996. Four family members who also ate the meat were 
hospitalized with the same symptoms. At admission, 
the patient was febrile (38.4OC) and experienced intense 
myalgia, diarrhea and periorbital edema compatible 
with trichinellosis; neurologic examination was normal 
and there was no sign of vasculitis; the white blood 
cell count was 13.5x1O9/L with 47% eosinophils; the 
serum creatine phosphokinase was 1448 U/L (normal 
range, 21-232 U/L); the alanine aminotransferase, 
aspartate aminotransferase and serum aldolase were, 
respectively, 2, 1.5 and 8 times normal values; the 
electrocardiogram was normal; stool analysis for 
parasites was negative. Trichinella serology was positive 
by immunofluorescence assay at a titer of 1/400 before 
and after 5 days of treatment. The patient responded 
well to a 10-day treatment with prednisone 0.5 mg/kg 
and albendazole 1600 mg daily. There were no 
abnormal clinical signs at follow-up on day 30. 
Since 1983, numerous outbreaks of human trichi- 
nellosis have been reported in the former Yugoslavia, 
affecting more than 2000 patients [4]. The increased 
number of cases may be attributable to the lack of, or 
insufficient, sanitary inspection of meat. People going 
to the former Yugoslavia, to visit or for an extended 
period of time, such as foreign military troops or 
humanitarian aides, must be warned of the risk of 
acquiring trichinellosis because of their potential 
exposure to infested, inadequately cooked pork. In 
addltion to this preventive role, Western physicians 
